Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.40 |
| ▸ | EGFR | P00533 | 3/20 | 0.38 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17839004 | 0.84 | CYP1A2 (0.40) | LPLLIPGEGFRPTGER3MAPT | |
| SCHEMBL18572048 | 0.83 | EGFR (0.40) | LPLLIPGEGFRPTGER3MAPT | |
| SCHEMBL26556057 | 0.81 | SYK (0.51) | LPLLIPGEGFRLMNASYK | |
| SCHEMBL18259410 | 0.79 | MAPT (0.34) | LPLLIPGEGFRPTGER3MAPT | |
| SCHEMBL3306133 | 0.78 | LPL (0.39) | LPLLIPGEGFRROCK1IDO1 | |
| SCHEMBL17838987 | 0.77 | LPL (0.36) | LPLLIPGEGFRMAPTMEN1 | |
| SCHEMBL20392597 | 0.77 | LPL (0.41) | LPLLIPGEGFRROCK1MAPT | |
| SCHEMBL29502756 | 0.77 | LPL (0.41) | LPLLIPGEGFRROCK1MAPT | |
| SCHEMBL15192688 | 0.76 | LPL (0.49) | LPLLIPGEGFRROCK1IDO1 | |
| SCHEMBL19418901 | 0.75 | MAPT (0.43) | LPLLIPGEGFRMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3237401-A1 | ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR | Pfizer Inc (US) | 2017-11-01 | — | — | EP | disclosed |
| US-9738626-B2 | Antagonists of prostaglandin EP3 receptor | PFIZER INC. (US) | 2017-08-22 | — | — | US | disclosed |
| WO-2016103097-A1 | ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR | PFIZER INC. (US) | 2016-06-30 | — | — | WO | disclosed |
| US-20160176851-A1 | ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR | PFIZER INC. (US) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176851-A1 | ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR | PTGER3, PTGES3, PTGER2 | LPL 1285/4885LIPG 953/4885EGFR 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.